Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Statement of Cash Flows [Abstract]    
Net income (loss) (1) $ 72,361 $ 233,258
Operating Activities:    
Depreciation and amortization (1) 25,642 26,013
Equity (income) loss from equity method investments 5 (75,641)
Acquisition (gain) loss 0 (136,873)
Non-cash debt and financing costs 635 1,124
(Gain) loss on early extinguishment of debt 0 486
Stock-based compensation expense 8,477 2,631
Provision for Doubtful Accounts 81 152
(Gain) loss on write down and disposal of long-lived assets 823 (20)
Pension and other post-retirement benefits 2,549 2,608
Change in deferred income taxes (1) 578 (126)
Change in operating assets (1) (19,956) 20,586
Change in operating liabilities (1) (58,049) (34,639)
Other (1) (147) 190
Net cash provided by (used in) operating activities (1) 32,999 39,749
Investing activities:    
Capital expenditures (40,478) (17,830)
Acquisitions, net of cash received 0 167,129
Proceeds from Sale of Productive Assets 0 600
Payments to Acquire Interest in Joint Venture (1,000) 0
Net cash provided by (used in) investing activities (40,702) 150,484
Financing activities:    
Payments of revolving line of credit 0 (33,881)
Proceeds from Issuance of Secured Debt 510 334,978
Payments of Debt Issuance Costs 0 (5,002)
Payment of long-term debt (8,625) (357,313)
Proceeds from exercise of stock options 471 4,066
Proceeds from Equity Method Investment, Distribution 776 585
Proceeds from Warrant Exercises 0 8,838
Net cash provided by (used in) financing activities (7,644) (48,314)
Net increase (decrease) in cash, cash equivalents and restricted cash (15,347) 141,919
Effect of foreign currency fluctuations on cash, cash equivalents and restricted cash (1) (8,452) 1,980
Cash, cash equivalents, and restricted cash at beginning of fiscal period 286,846 $ 109,774
Cash, cash equivalents, and restricted cash at end of fiscal period $ 263,047